HEALTH
& MEDICAL
Research
SUMMARY
STJOHNOFGODSubiacohospital
Anaesthesia and Pain Research Unit Key personnel Director of Anaesthesia and Pain Medicine.......................................... Dr Joe Pracilio Senior Research Fellow................... A/Prof Nolan McDonnell Research Nurse/ Co-ordinators............................. Yvonne Buller, Natalie Hird Nurse Practitioner.....................................................Jill Kelly Associate Research Fellows....................Prof Stephan Schug, ....................................................Clin Prof Tomas Corcoran
Projects
• Various audits have been performed investigating obstetric epidural management practice, paediatric pre-operative fasting, paediatric post-operative nausea and vomiting and analgesia documentation
Highlights
• The BALANCED Anaesthesia Study: A prospective, large (6,500 participants) randomised clinical trial of two levels of anaesthesia depth on patient outcome after major surgery. We are expected to be the highest recruiting hospital within Australia
“The SJGSH Experience”: The role of the Acute Pain Service Post Discharge Clinic in providing follow up and weaning support to our patients. Oral Presentation, April 2014, The Australian Pain Society 34th Scientific Meeting Presentation, Personalised Pain Management: A Quest for the Holy Grail, Hobart
• The PADDAG Trial: The Perioperative Administration of Dexamethasone and Blood Glucose Concentrations Trial will investigate the safety of dexamethasone, and measure rises in blood sugar and wound healing and infection in diabetic and non-diabetic patients
Providing early patient access to pain management. A Nurse Practitioner Service Conference Presentation, May 2014, Combined Australia New Zealand College of Anaesthetists & Royal College of Surgeons Annual Scientific Congress, Singapore
• PADDI: Perioperative Administration of Dexamethasone and Infection Trial will be a large global study involving 9,000 patients to investigate whether dexamethasone suppresses the immune system and if post-operative blood sugars rise in diabetic and non-diabetic patients
Nursing leadership in action: How other nurses perceive the role of the Acute Pain Service Nurse Practitioner. Oral Presentation, November 2014, International Congress of Nursing: Perth, Western Australia
• GRAB-Milk: A study of the transfer of gabapentin and pregabalin into breast milk will examine the transfer of gabapentin and pregabalin and test whether the infant dose received in breast milk is acceptable and insufficient to cause concern about significant adverse effects in the neonate • Towards an Understanding of the role of the Acute Pain Service Nurse Practitioner in a Private Setting: an assessment of satisfaction with the Nurse Practitioner service by patients, medical practitioners, nursing/ midwifery and pharmacy staff
2
• Opioids, Discharge and Acute Pain Management for Day Procedure Patients in a Private Hospital Setting will evaluate the formulation and doses of opioid analgesics prescribed for discharge, overall effectiveness and adverse effects, the ongoing opioid requirement 7-14 days post discharge and the amount of dispensed opioids that are unused
HEALTHANDMEDICALRESEARCHSUMMARY
An Overview of Pain Management and Assessment. Presentation and Workshop, November 2014, Australian College of Nursing, Pain Management Update: Perth, Western Australia Opioids, Discharge and Acute Pain Management for Day Procedure Patients in a Private Hospital Setting. Conference Presentation, November 2014, Research Opportunities Engagement Workshop: St John of God Healthcare and University of Notre Dame
“Clinical research is central to our ability to deliver effective and compassionate care to our patients. We are committed to finding innovative ways to improve our service and we aim to be a leading site for clinical trials, teaching and training in WA.” Dr Joe Pracilio
HEALTHANDMEDICALRESEARCHSUMMARY
3
STJOHNOFGODSubiacohospital
Bendat Family Comprehensive Cancer Centre Clinical Trial Unit Key personnel
Highlights
Project Manager Clinical Trials Development.............................................. Dr Jo Youd
OVAR2.21 (ANZGOG): (Highest recruiting site in Australia). A Prospective Randomized Phase III Trial of Carboplatin/Gemcitabine/Bevacizumab vs. Carboplatin/ Pegylated Liposomal Doxorubicin/Bevacizumab in Patients with Platinum-Sensitive Recurrent Ovarian Cancer
Senior Clinical Trial & Data Management Officer.................................. Skye Ridley Clinical Trial Compliance Officer....................Catherine May Clinical Trial & Data Management Officers........................... Karen Roberts, ............................................. Kathryn Jajko, Amanda Taylor, ................................................Laura Debry, Luke Hanrahan Medical/Surgical Oncologists.................... Dr Andrew Dean, ......................................... Dr Daphne Tsoi, Dr Siobhan Ng, ......................................... Dr Martin Buck, Dr Ru-Wen Teh, ................................... Dr Tim Clay, Dr Thomas Van Hagen, ..................................................... Prof Christobel Saunders Radiologists................ Dr Randall Oates, Dr Sirisha Madhala
Projects The Clinical Trial Unit currently runs a variety of trials for the following cancer types: • Breast Cancer • Prostate Cancer • Colorectal Cancer • Ovarian Cancer • Pancreatic Cancer • Merkel Cell Carcinoma • Non-Small Cell Lung Cancer
4
HEALTHANDMEDICALRESEARCHSUMMARY
ARIEL3 (Clovis Oncology): (Highest recruiting site in Australia). A Multicenter, Randomised, Double-Blind, Placebo-Controlled Phase 3 Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients with Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer ET743-OVC-3006 (JANSSEN): (Highest recruiting site in Australia). A Randomised, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer ICON8 (ANZGOG): (Highest recruiting site in Australia). An International Phase III Randomised Trial of Dose-Fractionated Chemotherapy Compared to Standard 3-weekly Chemotherapy, Following Immediate Primary Surgery or as Part of Delayed Primary Surgery, for Women with Newly Diagnosed Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer PROSTVAC (BNIT-PRV-301): (Highest recruiting site in Australia, in top 5 highest recruiting sites worldwide). A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC ± GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic, Castrate-Resistant Prostate Cancer
HEALTHANDMEDICALRESEARCHSUMMARY
5
STJOHNOFGODSubiacohospital
Pathology and Laboratory Medicine (with St John of God Pathology) Key personnel
Highlights
Director of Research........................................... Dr Nik Zeps
Waddell N et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature, 2015 Feb 26;518(7540):495-501
Operations Manager.....................................Dino Cercarelli Research Staff............................. Maria Beilin, Lisa Spalding, ...................................................Andrew Mews, Tim Miller, .................................................................Janelle Leadbitter Pathology Staff............................... Dr Christine Hemmings, .......................................... Dr Kerryn Garrett, Dr Marie Rye
Projects The Pathology and Laboratory Medicine group engages in a broad range of activities that are based upon research involving human biospecimens. The projects supported involve St John of God Subiaco Hospital groups and external collaborators. Our laboratory based services include: • Biobanking »» Clinical trial biospecimen processing »» Tissue Microarrays • Histopathology based research techniques • Tissue imaging and analysis • Molecular pathology External projects supported: • Australian Pancreatic Genome Initiative • Evaluation of molecular links between the EGFR pathway and up-regulation and mislocalisation of CDCP1 in colorectal cancer
Johns AL, Miller DK, Simpson SH, Gill AJ, Kassahn KS, Humphris JL, Samra JS, Tucker K, Andrews L, Chang DK, Waddell N, Pajic M, Australian Pancreatic Cancer Genome Initiative, Pearson JV, Grimmond SM, Biankin AV, Zeps N. Returning individual research results for genome sequences of pancreatic cancer. Genome Medicine, 2014, 6:42 (29 May 2014) Milius D, Dove ES, Chalmers D, Dyke SO, Kato K, Nicolás P, Ouellette BF, Ozenberger B, Rodriguez LL, Zeps N, Joly Y. The International Cancer Genome Consortium’s evolving data-protection policies. Nat Biotechnol, 2014 Jun 9;32(6):519-23 Collura A, Lagrange A, Svrcek M, Marisa L, Buhard O, Guilloux A, Wanherdrick K, Dorard C, Taieb A, Saget A, Loh M, Soong R, Zeps N, Platell C, Mews A, Iacopetta B, De Thonel A, Seigneuric R, Marcion G, Chapusot C, Lepage C, Bouvier AM, Gaub MP, Milano G, Selves J, Senet P, Delarue P, Arzouk H, Lacoste C, Coquelle A, Bengrine-Lefèvre L, Tournigand C, Lefèvre JH, Parc Y, Biard DS, Fléjou JF, Garrido C, Duval A. Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracil–based chemotherapy. Gastroenterology, 2014 Feb;146(2):401-11.e1 Wang Y, Ren F, Wang Y, Feng Y, Wang D, Jia B, Qiu Y, Wang S, Yu J, Sung JJ, Xu J, Zeps N, Chang Z. CHIP/Stub1 functions as a tumor suppressor and represses NF-κBmediated signaling in colorectal cancer. Carcinogenesis, 2014 May. 35(5):983-91
• The influence of gut microbiome and metabolome on liver injury in non-alcoholic fatty liver disease • Giant Cell Arteritis • CHIP/Stub1 functions as a tumour suppressor and repressed NF-κB-mediated signalling in colorectal cancer • Significance of activated EGFR and its signal transducers in human soft tissue sarcoma • HSPMMR A new splicing mutant in MSI colorectal cancer
6
HEALTHANDMEDICALRESEARCHSUMMARY
HEALTHANDMEDICALRESEARCHSUMMARY
7
STJOHNOFGODSubiacohospital
Breast Cancer Research Program Key personnel
Highlights
Surgical Oncologist........................ Prof Christobel Saunders
Cuzick J, Sestak I, Forbes J, Dowsett M, Knox J, Cawthorn S, Saunders CM, Roche N, Mansel R, von Minckwitz G, Bonanni B, Palva T, Howell A et al. Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial. The Lancet, 2014 (13)62292-8
Medical Oncologists................................... Dr Daphne Tsoi, ....................................... Dr Andrew Dean, Dr Siobhan Ng, ................................................Dr Ru-Wen Teh, Dr Tim Clay Breast Surgeons/ Senior Clinical Lecturers................................ Dr Lee Jackson, ............................................................. Dr Wen Chan Yeow Pathologist................................................Dr Bridget Cooke
Projects • ROLLIS (Radio-Occult Lesion Localization using Iodine Seeds): a randomised controlled trial investigating a novel technique for localizing impalpable cancers • Healthy Living after Cancer Trial: a telephone intervention promoting exercise • Exercise to prevent “chemo-brain”: an exercise programme • Peer Reviews of MDTs: improving function of multi-disciplinary teams by peer review feedback • Intra-op Breast Imaging Review: an audit of theatre imaging of breast cancers • National Tissue Bank of matched primary breast tumours and metastases obtained at autopsy – the BROCADE study: tissue collection to examine molecular and genetic changes in breast cancers from “warm autopsy” specimens • EMPathy: epithelial mesenchyme plasticity in breast cancer – clinical validation arm • “Microscope in a needle”: developing fluorescent markers to improve optical coherence tomography diagnosis of breast cancer • POSITIVE trial: interruption of endocrine therapy in young breast cancer patients who desire pregnancy
Corica T, Joseph D, Saunders CM, Bulsara M, Nowak A. Intraoperative radiotherapy for early breast cancer: do health professionals choose convenience or risk? A cross-sectional, questionnaire-based study. Radiation Oncology, 2014 doi:10.1186/1748-717X-9-33 Dessauvagie BF, Frost FA, Sterrett GF, Hardie M, Parry J, Latham B, Westcott E, Rourke T, Burrage J, Bourke A, Taylor D, Kamyab R, Saunders C. Handling of radioactive seed localisation breast specimens in the histopathology laboratory. The Western Australian Experience. Pathology, 2015, Vol.47(1), pp.21-6 Pagani O, Ruggeri M, Manunta S, Saunders C, Peccatori F, Cardoso F, Kaufman B, Paluch-Shimon S, Gewefel H, Gallerani E, Abulkhair O, Pistilli B, Warner E, Saloustros E, Perey L, Zaman K, Rabaglio M, Gelber S, Gelber RD, Godhirsch A, Korde L, Azim HA Jr, Partridge AH. Pregnancy after breast cancer: Are young patients willing to participate in clinical studies? Breast, 2015 Feb 4 (Epub ahead of print) Vagenas D, DiSipio T, Battistutta D, Demark-Wahnefried W, Rye S, Bashford J, Pyke C, Saunders C, Hayes SC. Weight and weight change following breast cancer: evidence from a prospective, population-based, breast cancer cohort study. BMC Cancer, 2015 Jan 31;15(1):28
“ Our vision is to establish St John of God Subiaco Hospital as a leading centre for breast cancer research and service excellence, in collaboration with partners both here in WA such as the Universities, research institutes and Cancer Council, to participate in research to improve the outcomes for our patients.” Prof Christobel Saunders
• Conquer Fear Study: psychosocial interventions in breast cancer patients
8
HEALTHANDMEDICALRESEARCHSUMMARY
HEALTHANDMEDICALRESEARCHSUMMARY
9
STJOHNOFGODSubiacohospital
Subiaco Hospital Laboratory WA Colorectal Cancer Research Group
Key personnel
Projects
• Morphology and Molecular Profiling on Interval Colorectal Cancers: Is procedural quality or molecular biology responsible?
Director of WA Colorectal Research Group....................Prof Cameron Platell
• Rectal cancer stem cells, the stroma and inflammation. Tissue Microarray construction, antibody optimisation staining of TMAs completed 2013
• Survival and recurrence in patients with stage I colorectal cancer
Consultant Pathologist............. A/Prof Christine Hemmings Clinical Nurse Coordinator..............................Cheryl Penter Postdoctoral Research Fellow.................. Dr Melanie McCoy Research Staff.........................Timothy Miller, Lisa Spalding, ....................................Tracey Lee-Pullen, Stephanie Austin, ..................................... Bonnie Zhang, Chidozie Anyaegbu Associate Investigators............................. Mr Michael Levitt, ..................................... Mr Gregory Makin, Mr Patrick Tan, ..................................... Dr Paul Salama, Dr Nigel Barwood, ...................................... Dr David Ransom, Dr Siobhan Ng, ..................................... Dr Daphne Tsoi, Dr Kerryn Garrett, .......................................................... Dr Sanjay Mukhedkar
10
HEALTHANDMEDICALRESEARCHSUMMARY
• Do regulatory T cells inhibit the response of rectal carcinomas to neoadjuvant chemoradiotherapy? • Assessment of CD47 and calreticulin gene expression in archived tumour tissue • Cancer stem cells as prognostic markers in colorectal cancer (PhD Project) • Development of a research informatics system – “Turtle”. Research database “Turtle” developed for colorectal cancer research and versions adapted for use in oncogenetic and gynaelogical research • Understanding the role of signalling molecules in colorectal cancer. Identification of suitable patients, provision of tissue samples, creation of TMAs
• The influence of adjuvant chemotherapy on patients with stage II colon cancer • The effect of rectal irrigation on bowel function following rectal cancer surgery (Clinical Trial)
Highlights
Platell, C et al. Influence of local recurrence on survival in patients with rectal cancer. ANZ Journal of Surgery, 2014, 84(1-2), 85-90 Loh M, Chua D, Yao Y, Soo R, Garrett KL, Zeps N, Platell CF, Minamoto C, Kawakami K, Iacopetta B.J, Soong R. Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies? Pharmacogenomics, 2013, 13, pp. 423-429 Sjoquist KM, Chin VT, Chantrill LA, O’Connor C, Hemmings C, Chang DK, Chou A, Pajic M, Johns AL, Nagrial M. Personalising pancreas cancer treatment: When tissue is the issue. World Journal of Gastroenterology, 2014 20(24): 7849
Schofield L et al. Population-based screening for Lynch syndrome in Western Australia. International Journal of Cancer, 2014, 135(5), 1085-1091 Theophilus M, Platell C, & Spilsbury K. Long-term survival following laparoscopic and open colectomy for colon cancer: a meta-analysis of randomised controlled trials. Colorectal Disease, 2014, 16(3), O75-O81
HEALTHANDMEDICALRESEARCHSUMMARY
11
STJOHNOFGODSubiacohospital
Gynaecologic Oncology Research Program Key personnel Gynaecological Oncologists.................... Dr Stuart Salfinger, ............................................................. Dr Jason Jit Sun Tan
• The somatic 402C>G FOXL2 mutation in ovarian granulosa cell tumours: does homozygosity confer a greater risk of recurrent disease?
Pathologist....................................................Dr Adeline Tan
• Targeting mTOR signaling in human ovarian cancer
Project Manager................................................. Sanela Bilic
• WA Gynaecologic Oncology (WAGO) Biospecimen Bank provides ethically obtained biospecimens for research, cross-referenced with the health information database. This infrastructure will enable researchers to define the clinico-pathological, molecular and therapeutic factors impacting on morbidity and mortality of patients in Western Australia
Research Fellow/ Clinical Senior Lecturer..................................Dr Paul Cohen ........................................(Jakovich Family Research Fellow) Medical Oncologists.........Dr Andrew Dean, Dr Martin Buck Research Assistant........................................Dawn Farquhar Affiliated Researchers................................... Prof Yee Leung, .................................Dr Raj Mohan, Prof Andreas Obermair PHD Student................................................ Dr Paige Tucker
Projects • Randomised trial to compare patient outcomes after laparoscopic hysterectomy with a 5mm vs a 10mm umbilical port • Malignant struma ovarii – papillary thyroid carcinoma in ovarian teratomas: correlation of CK-19 and HMBE-1 with tumour morphology, clinical outcome and BRAF mutation status • A Novel Surgical Technique for the Large Ovarian Cystic Mass – Combined Mini-Laparotomy and Laparoscopy • Mindfulness Based Cognitive Behavioural Therapy to Treat Fear of Recurrence in Ovarian Cancer Survivors (FROCS) – A Pilot Study • Sexuality and Quality of Life after Risk-Reducing Salpingo-Oophorectomy: a Retrospective Study • Sexual Healing: A Randomised, Controlled Trial on the Effect of Pre-Operative Sexual Counselling on Sexuality and Quality of Life after Risk-Reducing
12
Salpingo-Oophorectomy
HEALTHANDMEDICALRESEARCHSUMMARY
“ Our vision is to become a world-renowned centre of excellence – a leader in local, national and international gynaecologic cancer research, which will enable us to provide unparalleled care to our patients.” Dr Paul Cohen
Highlights Rosario R, Cohen P, Shelling AS. The role of FOXL2 in the pathogenesis of ovarian granulosa cell tumours. Gynecol Oncol, 2014 May; 133(2):382-7 Munro A, Codde J, Semmens J, Leung Y, Spilsbury K, Williams V, Steel N, Cohen P, Pavicic H, Westoby V, O’Leary P. Utilisation of co-testing (human papilloma virus DNA testing and cervical cytology) after treatment of CIN: a survey of GP’s awareness and knowledge. Australian Family Physician Vol 44, no 1-2, January – February 2015 Fitz-Gerald AL, Tan J, Chan K, Polyakov A, Edwards GN, Najjar H, Tsaltas J, Vollenhoven B, Comparison of Ultrasonic Shears and Traditional Suture Ligature for Vaginal Hysterectomy: Randomised Controlled Trial. The Journal of Minimally Invasive Gynecology, 2013, 20(6), 853–857 Acton J, Salfinger S. Effect of Umbilical Port and Endoscope Size on Discharge Times and postoperative Recovery after total laparoscopic hysterectomy: A retrospective review. Journal Gynaecologic Surgery, October 2014, 30(5): 273-275 Stewart CJ, Salfinger S, Spagnolo DV. Appendiceal hamartoma resembling PHTS of soft tissue in a patient with Cowden syndrome J Clin Pathol, 2014 Jan;67(1):81-3
HEALTHANDMEDICALRESEARCHSUMMARY
13
STJOHNOFGODSubiacohospital
Intensive Care Unit Research Program Key personnel
Highlights
Consultant Intensivists......................................Dr Ed Litton, ......................................A/Prof Kwok Ho, Dr David Morgan
Morgan DJ, Ho KM, Armstrong J, Litton E. Long-term Clinical Outcomes and Health Care Utilisation After Bariatric Surgery: A Population-Based Study. Ann Surg, 2014 Oct 30. [Epub ahead of print]
Research Officer....................................... Marlene Kolybaba
Projects The Utilisation Of Intensive Care Services After Bariatric Surgery 2007-11. This state-wide research project investigates all bariatric surgery undertaken in Western Australia over a five year period with emphasis placed on all admissions to an ICU after bariatric surgery. This dataset is the amalgamation of the Western Australian Department of Health Data Linkage Unit and a locally created database of all ICU admissions after bariatric surgery across all of Western Australia. At present this project is in the final processes of writing and publishing a series of manuscripts.
Proposed research projects • Audits: »» Postoperative fluid management after cardiothoracic surgery: A description of current ICU practice »» Sleep quality in patients admitted to the ICU • Systematic Reviews: »» Safety and Efficacy of epoietin in critically ill patients: A systematic review and meta-analysis • Prospective Observational Studies: »» Iron metabolism in patients receiving total parenteral nutrition: a prospective observational study • Randomised Controlled Trials:
Morgan DJ, Ho KM. Acute kidney injury in bariatric surgery patients requiring intensive care admission: a state-wide, multicenter, cohort study Surg Obes Related Dis, Available online 14 January 2015 [Epub ahead of print] Paul R, Morgan D, Levitt M, Baker R. Acute disseminated intravascular coagulation following surgical resection of a myeloid sarcoma in a 57-year-old male. Clin Pract, 2012 May 18;2(3):e57 Intensive Care for Physicians 2014: Dr David Morgan: SJOG Subiaco Medical Registrar Lecture Series August 20th 2014 The utilisation of intensive care services after bariatric surgery in Western Australia: Dr David Morgan: at the Australasian Society for the Perioperative Care of the Obese Patient Meeting. December 17th 2014. University Club, University of Western Australia
“ We are the busiest private ICU in Western Australia. We successfully established the ANZICS Adult Patient Database and have recently appointed a permanent part-time data collector. All this preparation has given our department the perfect springboard to cultivate an innovative research programme.” Dr David Morgan
»» Association between data presentation and perceived risk in surrogate-decision-makers in the ICU: A randomised comparative study
14
HEALTHANDMEDICALRESEARCHSUMMARY
HEALTHANDMEDICALRESEARCHSUMMARY
15
STJOHNOFGODSubiacohospital
Nursing, Midwifery and Allied Health Research Program Key personnel
Highlights
Nursing and Midwifery Research Coordinator................................... Dr Janie Brown
Brown J, Sims S. Nursing clinical handover in neonatal care. Contemporary Nurse: A Journal for the Australian Nursing Profession, Dec 2014, Vol.49, p.50-59
Research Nurse........................................... Alannah Cooper
Projects • Extending the Registered Midwife scope of practice – An innovative educational program for the Delivery Suite Operating Room • Nursing clinical handover in Neonatal Care • Evaluating a bereavement service • Eye Pledget Dilatation Procedure (Quality) • Towards an understanding of the role of the Nurse Practitioner in an Acute Pain Service in a private hospital setting • Communication at end of life • Measuring leadership development: Can a targeted education program promote a culture of clinical leadership? • Journals clubs: Developing a culture of research • Assessing carer support needs in palliative care in preparation for patient discharge from an acute setting – A feasibility study • Nursing and midwifery research priorities at a private hospital in Western Australia – A replication study • Time of last void documentation at time of arrival in holding bay (Quality)
16
HEALTHANDMEDICALRESEARCHSUMMARY
Brown JA, Gardner J. Supporting grieving relatives through a structured Bereavement Service. Health Matters, 2015 (72), 20-22 Cross L, Brown JA. Clinical leadership capacity building: How Nurse managers and Directors perceive the Clinical Nurses and Midwives leadership role. Paper presented at 7th International Congress on Innovations in Nursing, Perth, Australia, 2014 Kelly J, Brown JA, Fraser J, Working together to provide early patient access to acute pain management in a private hospital setting: Multidisciplinary team and patient perspectives of an Acute Pain Service Nurse Practitioner Service. Paper presented at Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine ASM 2014, Singapore Kelly J. Personalised Pain Management: A Quest for the Holy Grail. Paper presented at The Australian Pain Society 34th Scientific Meeting 2014, Hobart, Australia
“ Looking forward to 2015, Nursing, Midwifery and Allied Health Research is well positioned. Through a number of key research collaborations and with an increasingly capable workforce, our research will continue to improve outcomes for our patients and their families, and our caregivers.” Dr Janie Brown
HEALTHANDMEDICALRESEARCHSUMMARY
17
STJOHNOFGODSubiacohospital
Perinatal Infant and Maternal Mental Health
How you can help
Key personnel
Highlights
Director of Psychiatry/ Adjunct Associate Professor.....................Dr Caroline Zanetti
Zanetti CA, Harrison B, Feutrill J, Clifford A. A Competence Framework for Perinatal and Infant Mental Health Assessment (the SJG Subiaco Competence Framework). Submitted for review by experts in the national and international field. Planned for publication on SJGSH website in 2015
At St John of God Subiaco Hospital we are committed to providing exceptional care.
Projects • Screening and early intervention for mothers with postnatal mood disorder and/or problems in their relationship with their baby
Zanetti C. The Take Up of Postnatal Services (TUPS) Study. Poster presented at RANZCP 2014 Congress, 11-15 May 2014, Perth WA
• Evaluation of a therapeutic intervention is underway: Development of an observational screening tool is a project planned for 2016. This will be quite a complex and lengthy area of investigation
Integrated assessment in perinatal and infant mental health: a comprehensive competency-based approach to informed care of parents, infants and the relationships they share. Workshop at RANZCP 2014 Congress, 11-15 May 2014, Perth WA
• My Baby Study: Population study to be conducted at the Royal Show to establish norms for a brief self-report parent-infant relationship measure, the Mother Object Relations Scale Short Form (MORS-SF) and prevalence of relationship disorder • A competence framework for assessment in perinatal and infant mental health (Subiaco Assessment Competences) • Utility of the Montgomery and Asberg Depression Rating Scale (MADRS) in perinatal assessment • Neonatal Nurses’ Perception of their Work
Perinatal (and infant) psychiatry. Invited Speaker, RANZCOG 2014 Regional Scientific Meeting, 20-22 June, Broome, WA The Mind, Brain & Nervous System. Event One: The Mind, ‘Perinatal and infant mental health: psychological care of mothers and babies.’ Invited Speaker, SJGSH GP Presentation Series, 23 June, 2014
Our reputation ensures we attract the leading medical specialists. Furthermore, our nurses are well recognised for their ability to combine the highest clinical standards with compassion and patient centred care. The excellence in our people is complemented with unprecedented investment in medical technology to ensure that combined, we achieve the best possible clinical outcomes. As a not-for-profit hospital, we rely on the generous support of our donors and sponsors to continue our work in providing first class care to over 70,000 patients per year. Your gift will allow St John of God Subiaco Hospital to advance disease areas that are important to you. Together, we have the power to touch thousands of families and alleviate suffering in our community and throughout Western Australia. Thank you.
Make a gift towards Anaesthesia & Pain Medicine Breast Cancer Research Bowel Cancer Research Cardiology Research Critical Care Research Gynecological Cancer Research Nursing & Midwifery Research Oncology Research Orthopaedics Palliative Care
About St John of God Subiaco Hospital St John of God Subiaco Hospital is one of Western Australia’s largest not-for-profit private hospitals, providing a comprehensive range of medical and surgical services on one campus. We provide the latest in evidence based treatments across 30 specialty areas including Obstetrics and Gynaecology, Oncology, Cardiology and Cardiothoracic Surgery, Orthopaedics, Urology and Neurosurgery. Our specialists, caregivers and support teams care for our patients 24 hours a day, 7 days a week.
18
HEALTHANDMEDICALRESEARCHSUMMARY
HEALTHANDMEDICALRESEARCHSUMMARY
19
Thank you to all our research scholarship and equipment benefactors. Attwell & Kelly Carcione Group of Companies Cooper & Oxley M Crossley B D’Souza Erceg Management Pty Ltd Geographe Garden Club Iannello Family Jako Group Kailis Family Foundation G Makin McCusker Foundation Richardson Foundation Rifici Family Rod Jones Family Charitable Trust P Shadforth Somas Family Stannard Family The Jack Family Charitable Trust The Stan Perron Charitable Foundation
If you would like to help, please contact our Foundation Office for a confidential conversation. St John of God Foundation Inc T. (O8) 9382 4292 E. foundation.donations@sjog.org.au www.sjog.org.au/foundation Published May 2015